Pharmaceutical priority setting and the use of health economic evaluations: a systematic literature review.
(2011) In Value in Health 14(4). p.587-599- Abstract
- To investigate which factors and criteria are used in priority setting of pharmaceuticals, in what contexts health economic evaluations are used, and barriers to the use of health economic evaluations at micro, meso, and macro health-care levels.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/2008118
- author
- Erntoft, Sandra LU
- organization
- publishing date
- 2011
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Value in Health
- volume
- 14
- issue
- 4
- pages
- 587 - 599
- publisher
- Wiley-Blackwell
- external identifiers
-
- wos:000299080800025
- pmid:21669384
- scopus:79960013935
- pmid:21669384
- ISSN
- 1098-3015
- DOI
- 10.1016/j.jval.2010.10.036
- language
- English
- LU publication?
- yes
- id
- 74c5518d-1dac-499a-8f4e-e18627546d8f (old id 2008118)
- date added to LUP
- 2016-04-01 10:09:50
- date last changed
- 2022-01-25 20:25:30
@article{74c5518d-1dac-499a-8f4e-e18627546d8f, abstract = {{To investigate which factors and criteria are used in priority setting of pharmaceuticals, in what contexts health economic evaluations are used, and barriers to the use of health economic evaluations at micro, meso, and macro health-care levels.}}, author = {{Erntoft, Sandra}}, issn = {{1098-3015}}, language = {{eng}}, number = {{4}}, pages = {{587--599}}, publisher = {{Wiley-Blackwell}}, series = {{Value in Health}}, title = {{Pharmaceutical priority setting and the use of health economic evaluations: a systematic literature review.}}, url = {{http://dx.doi.org/10.1016/j.jval.2010.10.036}}, doi = {{10.1016/j.jval.2010.10.036}}, volume = {{14}}, year = {{2011}}, }